Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.2T | 3.8T | 3.9T | 4.5T |
| Cost of revenue | 3.0T | 3.2T | 3.2T | 3.5T |
| Gross profit | 202.3B | 571.2B | 757.8B | 988.8B |
| Operating expense | ||||
| Research & development | 357.0B | 311.5B | 311.4B | 355.9B |
| Selling general and admin | 193.2B | 407.5B | 192.3B | 193.2B |
| Other operating expenses | — | 0 | 4.8M | — |
| Operating income | -434.1B | -256.7B | 129.9B | 280.2B |
| Non operating interest income | ||||
| Income | 9.9B | 15.5B | 14.8B | 13.0B |
| Expense | 85.3B | 82.5B | 87.2B | 88.3B |
| Other income expense | — | — | — | — |
| Pretax income | -357.1B | -347.2B | 266.5B | 377.4B |
| Tax provision | -135.5B | -95.1B | 39.8B | 76.2B |
| Net income | -216.0B | -242.7B | 230.4B | 301.2B |
| Basic EPS | -3.2K | — | 3.4K | 4.7K |
| Diluted EPS | -3.2K | — | 3.4K | 4.7K |
| Basic average shares | 68.1M | — | 68.1M | 68.1M |
| Diluted average shares | 68.1M | — | 68.1M | 68.1M |
| EBITDA | 244.3B | 429.4B | 852.9B | 967.0B |
| Net income from continuing op. | -216.0B | -242.7B | 230.4B | 301.2B |
| Minority interests | -4.6B | 16.2B | -687.6M | 21.8B |
| Preferred stock dividends | — | — | — | — |